Peng and colleagues272 developed an AD model by subcutaneously injecting mice with 2,4‐dinitrochlorobenzene (DNCB) for 33 days, combined with anti‐mouse IL‐33 antibody treatment. This evidence concerns the gene IL33 and Alzheimer disease.